Pleiotrophin (PTN) also known as heparin-binding brain mitogen (HBBM) or heparin-binding growth factor 8 (HBGF-8) or neurite growth-promoting factor 1 (NEGF1) or heparin affinity regulatory peptide (HARP) or heparin binding growth associated molecule (HB-GAM) is a protein that in humans is encoded by the PTNgene.[1] Pleiotrophin is an 18-kDa growth factor that has a high affinity for heparin. It is structurally related to midkine and retinoic acid induced heparin-binding protein.
Pleiotrophin was initially recognized as a neurite outgrowth-promoting factor present in rat brain around birth[2] and as a mitogen toward fibroblasts isolated from bovine uterus tissue.[3] Together with midkine these growth-factors constitute a family of (developmentally regulated) secreted heparin-binding proteins[4] now known as the neurite growth-promoting factor (NEGF) family. During embryonic and early postnatal development, pleiotrophin is expressed in the central and peripheralnervous system and also in several non-neural tissues, notably lung, kidney, gut and bone.[5] Pleiotrophin is also expressed by several tumor cells and is thought to be involved in tumor angiogenesis.[6] In the adult central nervous system, pleiotrophin is expressed in an activity-dependent manner in the hippocampus[7][8] where it can suppress long term potentiation induction.[9] Pleiotrophin expression is low in other areas of the adult brain, but it can be induced by ischemic insults.[10][11] or targeted neuronal damaged in the entorhinal cortex or in the substantia nigra pars compacta.
Clinical significance
Pleiotrophin binds to cell-surface nucleolin as a low affinity receptor. This binding can inhibit HIV infection.[12]
↑Vanderwinden JM, Mailleux P, Schiffmann SN, Vanderhaeghen JJ (1992). "Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues". Anat. Embryol. 186 (4): 387–406. doi:10.1007/BF00185989. PMID1416088.
↑Wanaka A, Carroll SL, Milbrandt J (1993). "Developmentally regulated expression of pleiotrophin, a novel heparin binding growth factor, in the nervous system of the rat". Brain Res. Dev. Brain Res. 72 (1): 133–44. doi:10.1016/0165-3806(93)90166-8. PMID8453763.
↑Lauri SE, Taira T, Kaila K, Rauvala H (1996). "Activity-induced enhancement of HB-GAM expression in rat hippocampal slices". NeuroReport. 7 (10): 1670–4. doi:10.1097/00001756-199607080-00029. PMID8904779.
↑Pavlov I, Võikar V, Kaksonen M, Lauri SE, Hienola A, Taira T, Rauvala H (2002). "Role of heparin-binding growth-associated molecule (HB-GAM) in hippocampal LTP and spatial learning revealed by studies on overexpressing and knockout mice". Mol. Cell. Neurosci. 20 (2): 330–42. doi:10.1006/mcne.2002.1104. PMID12093164.
↑Takeda A, Onodera H, Sugimoto A, Itoyama Y, Kogure K, Rauvala H, Shibahara S (1995). "Induction of heparin-binding growth-associated molecule expression in reactive astrocytes following hippocampal neuronal injury". Neuroscience. 68 (1): 57–64. doi:10.1016/0306-4522(95)00110-5. PMID7477935.
↑Said EA, Courty J, Svab J, Delbé J, Krust B, Hovanessian AG (September 2005). "Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin". FEBS J. 272 (18): 4646–59. doi:10.1111/j.1742-4658.2005.04870.x. PMID16156786.
Further reading
Milner PG, Shah D, Veile R, et al. (1993). "Cloning, nucleotide sequence, and chromosome localization of the human pleiotrophin gene". Biochemistry. 31 (48): 12023–8. doi:10.1021/bi00163a009. PMID1457401.
Li YS, Hoffman RM, Le Beau MM, et al. (1993). "Characterization of the human pleiotrophin gene. Promoter region and chromosomal localization". J. Biol. Chem. 267 (36): 26011–6. PMID1464612.
Tezuka K, Takeshita S, Hakeda Y, et al. (1991). "Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissues". Biochem. Biophys. Res. Commun. 173 (1): 246–51. doi:10.1016/S0006-291X(05)81048-4. PMID1701634.
Wellstein A, Fang WJ, Khatri A, et al. (1992). "A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine". J. Biol. Chem. 267 (4): 2582–7. PMID1733956.
Kretschmer PJ, Fairhurst JL, Decker MM, et al. (1992). "Cloning, characterization and developmental regulation of two members of a novel human gene family of neurite outgrowth-promoting proteins". Growth Factors. 5 (2): 99–114. doi:10.3109/08977199109000275. PMID1768439.
Li YS, Milner PG, Chauhan AK, et al. (1991). "Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity". Science. 250 (4988): 1690–4. doi:10.1126/science.2270483. PMID2270483.
Huber D, Gautschi-Sova P, Böhlen P (1990). "Amino-terminal sequences of a novel heparin-binding protein from human, bovine, rat, and chick brain: high interspecies homology". Neurochem. Res. 15 (4): 435–9. doi:10.1007/BF00969930. PMID2388713.
Asundi VK, Carey DJ (1995). "Self-association of N-syndecan (syndecan-3) core protein is mediated by a novel structural motif in the transmembrane domain and ectodomain flanking region". J. Biol. Chem. 270 (44): 26404–10. doi:10.1074/jbc.270.44.26404. PMID7592855.
Raulo E, Chernousov MA, Carey DJ, et al. (1994). "Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3)". J. Biol. Chem. 269 (17): 12999–3004. PMID8175719.
Fabri L, Maruta H, Muramatsu H, et al. (1993). "Structural characterisation of native and recombinant forms of the neurotrophic cytokine MK". J. Chromatogr. 646 (1): 213–25. doi:10.1016/S0021-9673(99)87023-X. PMID8408430.
Kretschmer PJ, Fairhurst JL, Hulmes JD, et al. (1993). "Genomic organization of the human HBNF gene and characterization of an HBNF variant protein as a splice mutant". Biochem. Biophys. Res. Commun. 192 (2): 420–9. doi:10.1006/bbrc.1993.1432. PMID8484754.
Hulmes JD, Seddon AP, Decker MM, Böhlen P (1993). "Comparison of the disulfide bond arrangements of human recombinant and bovine brain heparin binding neurite-promoting factors". Biochem. Biophys. Res. Commun. 192 (2): 738–46. doi:10.1006/bbrc.1993.1476. PMID8484780.
Kinnunen T, Raulo E, Nolo R, et al. (1996). "Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface". J. Biol. Chem. 271 (4): 2243–8. doi:10.1074/jbc.271.4.2243. PMID8567685.
Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome Res. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID8889548.
Masuda H, Tsujimura A, Yoshioka M, et al. (1997). "Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1". Biochem. Biophys. Res. Commun. 238 (2): 528–33. doi:10.1006/bbrc.1997.7188. PMID9299545.
Milev P, Chiba A, Häring M, et al. (1998). "High affinity binding and overlapping localization of neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta with tenascin-R, amphoterin, and the heparin-binding growth-associated molecule". J. Biol. Chem. 273 (12): 6998–7005. doi:10.1074/jbc.273.12.6998. PMID9507007.
Fages C, Kaksonen M, Kinnunen T, et al. (1998). "Regulation of mRNA localization by transmembrane signalling: local interaction of HB-GAM (heparin-binding growth-associated molecule) with the cell surface localizes beta-actin mRNA". J. Cell Sci. 111 (20): 3073–80. PMID9739080.
Zhang N, Zhong R, Deuel TF (1999). "Domain structure of pleiotrophin required for transformation". J. Biol. Chem. 274 (19): 12959–62. doi:10.1074/jbc.274.19.12959. PMID10224041.
Bernard-Pierrot I, Héroult M, Lemaître G, et al. (2000). "Glycosaminoglycans promote HARP/PTN dimerization". Biochem. Biophys. Res. Commun. 266 (2): 437–42. doi:10.1006/bbrc.1999.1835. PMID10600521.
Murasugi A, Kido I, Kumai H, Asami Y (2003). "Efficient production of recombinant human pleio-trophin in yeast, Pichia pastoris". Biosci. Biotechnol. Biochem. 67 (10): 2288–90. doi:10.1271/bbb.67.2288. PMID14586125.